|
NANP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.60139999985753E-07 |
| Normal-vs-Stage3 |
8.88178419700125E-16 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.305800E-02 |
| Stage1-vs-Stage3 |
7.176600E-01 |
| Stage1-vs-Stage4 |
9.220000E-04 |
| Stage2-vs-Stage3 |
2.924000E-02 |
| Stage2-vs-Stage4 |
9.75960000000331E-05 |
| Stage3-vs-Stage4 |
1.376170E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.82450000014201E-07 |
| Normal-vs-Asian |
3.15303338993544E-13 |
| Caucasian-vs-AfricanAmerican |
6.628800E-01 |
| Caucasian-vs-Asian |
8.189200E-01 |
| AfricanAmerican-vs-Asian |
6.529200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99840144432528E-15 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
6.150800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64135371960583E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
7.05302483083869E-12 |
| Normal-vs-Age(81-100Yrs) |
2.647500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.496200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.069800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.434400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.902400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.411000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.631000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.061510E-02 |
| Classical-VS-Follicular |
2.911800E-01 |
| Classical-VS-Other |
4.221400E-01 |
| Classical-VS-Normal |
2.58915111572833E-12 |
| Tall-VS-Follicular |
4.223400E-03 |
| Tall-VS-Other |
9.268800E-01 |
| Tall-VS-Normal |
1.63435931455069E-12 |
| Follicular-VS-Other |
2.886800E-01 |
| Follicular-VS-Normal |
1.85429449572894E-11 |
| Other-VS-Normal |
2.397300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
3.33066907387547E-16 |
| N0-vs-N1 |
1.109790E-02 |
|
|
